Kazimierz Groen (Kaz Groen)

Years Active: 2024-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Kazimierz Groen, Febe Smits, Kazem Nasserinejad, Mark-David Levin, Josien C Regelink, Gert-Jan Timmers, Esther G M de Waal, Matthijs Westerman, Gerjo A Velders, Koen de Heer, Rineke B L Leys, Roel J W van Kampen, Claudia A M Stege, Maarten R Seefat, Inger S Nijhof, Ellen van der Spek, Saskia K Klein, Niels W C J van de Donk, Paula F Ypma, Sonja Zweegman
Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes. HemaSphere 8 (7) (2024)
Kazimierz Groen, Febe Smits, Kazem Nasserinejad, Mark-David Levin, Josien C Regelink, Gert-Jan Timmers, Esther G M de Waal, Matthijs Westerman, Gerjo A Velders, Koen de Heer, Rineke B L Leys, Roel J W van Kampen, Claudia A M Stege, Maarten R Seefat, Inger S Nijhof, Ellen van der Spek, Saskia K Klein, Niels W C J van de Donk, Paula F Ypma, Sonja Zweegman
Assessing frailty in myeloma: The pursuit of simplicity may sacrifice precision of predicting clinical outcomes. HemaSphere 8 (7) (2024)
Charlotte L B M Korst, Kazimierz Groen, Patricia W C Bosman, Fleur van der Valk, Christie P M Verkleij, Sandy Kruyswijk, Maaike E M de Ruijter, Dianne M Heijink, Maria T Kuipers, Sonja Zweegman, Niels W C J van de Donk
Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step-up dosing. HemaSphere 8 (7) (2024)

Kazimierz Groen.css-eqlu8i{font-size:small;padding-left:4px;} (Kaz Groen)